Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/22/2022
CDE Seeks Comments on Draft Chinese Translation and Implementation Sug...
2/22/2022
CDE Publicizes the Draft CDE Working Procedures for Accelerating Evalu...
2/22/2022
Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
2/22/2022
State Council Issues New Plan on Senior Population Development and Eld...
2/21/2022
245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...
2/21/2022
Is China's Healthcare Industry the Next Regulatory Flashpoint under Bi...
2/21/2022
Why Patient-Centric Innovation Holds the Key to Long-Term Business Suc...
2/21/2022
Inter-Provincial Pacts on Bulk-Buying Drugs Are on the Rise in China, ...
2/21/2022
Cross-border Medical Data Compliance in New Era of Regulation
2/21/2022
Trends in China's Investigational New Drug Applications (PharmCube)
2/21/2022
PharmaDJ's China NMPA Approval Tracker: JAK Inhibitors Take Center Sta...
2/18/2022
CDE Issues the Technical Guidelines for Study on Mixing Uniformity and...
2/18/2022
CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH E...
2/18/2022
CDE Solicits Comments on the Draft Guidelines for Drug Registration Ac...
2/18/2022
Recent Executive Moves
2/18/2022
Drug R&D and Product Registration News Digest February 2022 (2)
2/17/2022
Novartis Eyes China Potential as Part of Its Strategy to Offset Billio...
2/17/2022
Innovent Ready to Challenge Amgen and Sanofi in PCSK9 Inhibitor Market...
2/17/2022
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...
2/17/2022
Chinese Pharmaceutical Cross-Border M&A in 2022 (PharmExec)
2/16/2022
FDA Places Phase 1 Trial of Legend's Early-stage CAR-T on Hold
2/16/2022
SciNeuro and Alamar Collaborate to Discover Novel Therapeutic Antibodi...
2/16/2022
Organon Acquires Bayer's Contraceptive Products Marvelon and Mercilo...
2/16/2022
USTR: China Falling Short on WTO Compliance and New Trade Tools Are N...
2/16/2022
Information Collection on the 7th VBP Officially Initiated by the JPO
2/16/2022
CDE Issues the Technical Guidelines on Clinical Trial of Antiviral The...
2/15/2022
Snapshot of MNC Pharma's China Performance in 2021
2/15/2022
Moderna Announces Plan to Expand Footprint in Asia with Four Additiona...
2/15/2022
China Faces Fresh Health Crisis as Experts Discover Alarming Heart Con...
2/15/2022
ChinaBio Partnering Forum Acquired by EBD Group/Informa
Page:
93
/
719
Total number of articles:
21546
:
[First]
[<<]
[91]
[92]
[93]
[94]
[95]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit